Barrington Research Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $38.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target reduced by Barrington Research from $41.00 to $38.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock.

Several other analysts also recently weighed in on the stock. SVB Leerink began coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an outperform rating and a $42.00 target price on the stock. Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research note on Friday. StockNews.com raised DENTSPLY SIRONA from a hold rating to a buy rating in a research note on Friday, January 19th. Piper Sandler reaffirmed a neutral rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday. Finally, Leerink Partnrs reiterated an outperform rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of Moderate Buy and a consensus target price of $35.89.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $28.29 on Friday. The stock has a fifty day simple moving average of $32.13 and a 200-day simple moving average of $32.71. The company has a current ratio of 1.43, a quick ratio of 0.95 and a debt-to-equity ratio of 0.54. The stock has a market cap of $5.87 billion, a PE ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. During the same quarter last year, the firm posted $0.39 earnings per share. DENTSPLY SIRONA’s revenue was down 2.6% compared to the same quarter last year. Equities analysts anticipate that DENTSPLY SIRONA will post 2.04 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.26%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Exchange Traded Concepts LLC grew its stake in shares of DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 439 shares in the last quarter. Asset Management One Co. Ltd. lifted its holdings in DENTSPLY SIRONA by 5.0% during the 3rd quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock worth $3,069,000 after buying an additional 4,294 shares during the last quarter. Xponance Inc. boosted its position in shares of DENTSPLY SIRONA by 12.4% during the 3rd quarter. Xponance Inc. now owns 37,292 shares of the medical instruments supplier’s stock worth $1,274,000 after acquiring an additional 4,114 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of DENTSPLY SIRONA by 132.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock valued at $2,863,000 after acquiring an additional 47,748 shares during the last quarter. Finally, Strs Ohio raised its position in shares of DENTSPLY SIRONA by 14.6% during the 3rd quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock worth $1,611,000 after acquiring an additional 6,021 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.